ESTUTC-5 New YorkLog in Sign up

RADX
Radiopharm Theranostics Limited
stockNASDAQADR

Market OpenNov 6, 2026 10:42:14 AM EST

0.92USD+8.234%(+0.07)22,057

Pre-marketNov 6, 2026 9:28:30 AM EST

0.9199USD+8.211%(+0.0698)

0.7500Bid1.0500Ask0.3000Spread

Loading…

Loading…

14.68M

Previous Close

$0.86

Beta

-0.93

52-Week High

$16.25 2025-12-15

52-Week Low

$0.82 2026-11-04

SMA 50

$1.46

SMA 200

$3.60

Avg. Vol 10D

67,171

Avg. Vol 30D

56,925

Avg. Vol 90D

75,118

Relative Vol

0.36

15.70M

819,522

5.22%

141,864

Short Interest %

17.31%

2.36

On/Off Exchange

49%/51%

40.78%

Short Vol % (off-exch)

35.71%

7.4500%

450,000

7,000

4,354

9,000

Nov 4, 2026

07:00 AM ESTRadiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases ·

GlobeNewswire Inc.

Nov 3, 2026

07:49 PM ESTRadiopharm Theranostics and FDA Agree on Design of Phase 3 RAD101 Trial for Brain Metastases ·

Small Caps

Nov 2, 2026

08:00 AM ESTRadiopharm Theranostics Reports Business Update ·

GlobeNewswire Inc.

RADX Performance

Period	Price	Date	Change	Beta
1W	1.08	2026-10-30	-13.43%	-1.322
1M	1.18	2026-10-06	-20.76%	-0.424
3M	2.79	2026-08-06	-66.49%	-0.311
6M	4.25	2026-05-06	-78.00%	-0.059
1Y	4.53	2025-11-06	-79.36%	-0.925
2Y	17.67	2024-12-05	-94.71%	—

RADX Stock Summary

Radiopharm Theranostics Limited (NASDAQ:RADX) stock price today is $0.94, and today's volume is 20,579. RADX is up 5.174% today. The 30 day average volume is 56,925. RADX market cap is $14.68M with 15.70M shares outstanding.